AJJ Medtech (SGX:584) narrowed its attributable loss in Q3 to SG$795,000 from SG$1.0 million a year earlier, according to a Wednesday filing with the Singapore Exchange.
Shares of the company were down over 9% in Thursday trading.
Loss per share came in at SG$0.00053 compared with SG$0.00079 in the comparable period.
Revenue jumped 87% year over year to SG$483,000 from SG$259,000, mainly due to improve performance from the healthcare products and services segment.